borderline significancep = 0.052
The HDL cholesterol level was increased by 9% in the 4 mg pitavastatin group with borderline significance ( p = 0.052); however, no change was observed in the pravastatin group ( p = 0.635).
The HDL cholesterol level was increased by 9% in the 4 mg pitavastatin group with borderline significance ( p = 0.052); however, no change was observed in the pravastatin group ( p = 0.635).